COMMUNIQUÉS West-GlobeNewswire

HMS to Report Second Quarter Financial Results on August 2, 2019
12/07/2019
IRVING, Texas, July 12, 2019 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (Nasdaq: HMSY) today announced it will report financial and operating results for the second quarter and six-month period ended June 30, 2019 on Friday [...]
Olainfarm Group sales in the first half of the year increased by 7%
12/07/2019
Preliminary consolidated results for the first six months of 2019 demonstrate an increase by 7%, compared to the six-month period of 2018, reaching 66.3 million euros. Preliminary consolidated results of JSC Olainfarm [...]
NeuBase Therapeutics Closes Merger Transaction with Ohr Pharmaceutical
12/07/2019
Company expects to initiate trading on NASDAQ Under Ticker Symbol “NBSE” effective July 15, 2019 Company completes previously announced financing of approximately $9 million immediately prior to closing of the merger [...]
Progenics Announces Preliminary Voting Results of Annual Meeting of Shareholders
12/07/2019
Commences Search Process to Identify New Board Candidates, Welcomes Input from All Shareholders NEW YORK, July 12, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing [...]
Generex Biotechnology Announces Closing on Acquisition of MediSource Partners
12/07/2019
Medisource Partners is an FDA registered distributor with an extensive portfolio of medical and surgical products including bone grafts and biologics Partnerships and contracts with hospital systems for ordering, [...]
Sonoma Pharmaceuticals Regains Compliance with Nasdaq® Minimum Bid Price Rule
12/07/2019
PETALUMA, Calif., July 12, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company dedicated to identifying, developing and commercializing unique, differentiated [...]
Teladoc Health to Announce Second-Quarter 2019 Financial Results
12/07/2019
PURCHASE, NY, July 12, 2019 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will release second-quarter 2019 results on Wednesday, July 31st, 2019, [...]
Aptinyx Salutes Retiring Chief Scientific Officer and NMDA Receptor Drug Discovery Pioneer, Joseph Moskal
12/07/2019
EVANSTON, Ill., July 12, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Medovex Corporation Announces Name Change to H-CYTE and New Ticker Symbol
12/07/2019
Company’s Shares to Trade Under Symbol “HCYT” at Opening of Trading on July 15, 2019 TAMPA, Fla., July 12, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today announced that FINRA has approved the effectiveness [...]
Middlefield Health & Wellness ETF Distributions
12/07/2019
CALGARY, Alberta, July 12, 2019 (GLOBE NEWSWIRE) -- Middlefield Health & Wellness ETF (TSX: HWF) (the “Fund”) is pleased to announce that distributions for the third quarter of 2019 will be payable to unitholders of [...]
RAFARMA Welcomes New CEO Vladimir Dolgolenko
12/07/2019
Ljubljana, Slovenia, July 12, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to the appointment of Vladimir Dolgolenko as its new CEO and President. Mr. Srečo Bojt shall remain as a company [...]
Le Dr Seth Forman a été nommé pour présider la seconde étude de phase 2 sur le bermekimab de XBiotech dans la dermatite atopique
12/07/2019
Une prochaine étude randomisée, en double aveugle et contrôlée contre placebo de phase 2 suit l'étude ouverte réussie sur la dermatite atopique (DA) AUSTIN, Texas, 12 juill. 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : [...]
CureVac to Participate in Two Panels at the ROTH RNA Revolution Conference
12/07/2019
TÜBINGEN, Germany and BOSTON, July 12, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichella, Chief Executive [...]
Genmab and BliNK Biomedical Enter into Commercial License Agreement
12/07/2019
Media Release Copenhagen, Denmark, July 12, 2019 Genmab and BliNK Biomedical have entered into a commercial license agreement to develop novel bispecific therapeutics based on BliNK Biomedical’s CD47 antibodies and [...]
Monthly information regarding the total number of voting rights and total number of shares of the Company
12/07/2019
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
12/07/2019
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Notice Convening the Extraordinary General Meeting
12/07/2019
July 12, 2019 Announcement no. 13 NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING The Board of Directors hereby convenes an Extraordinary General Meeting of BioPorto A / S (the “Company”): August 15, 2019, at 2.00 pm [...]
C-RAD and Elekta sign agreement to distribute C-RAD’s cutting-edge SIGRT solutions in America
12/07/2019
C-RAD and Elekta announced today a sales and distribution agreement for the North American and Mexican market. The agreement enables Elekta to offer C-RAD’s surface image guided radiation therapy (SIGRT) technology for [...]
ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) July 17, 2019 in New York City
12/07/2019
Geneva, Switzerland and Boston, MA – July 12, 2019 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

Pages